We must know our population, says Tinubu
April 17, 2025
AbbVie Cuts 2022 Earnings Outlook Due to Acquired In-Process R&D
American biopharmaceutical firm AbbVie has downgraded its earnings outlook for the year due to in-process research and development expenses recorded ...